The Sanford-Burnham Medical Research Institute granted Oncothyreon exclusive, worldwide rights to sabutoclax and related compounds

Sanford-Burnham Medical Research Institute

U.S. / Non-Profit or Major Disease Foundation

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Oncothyreon Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

$294.5m on 09/16/2011 [market cap]

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced